Compile Data Set for Download or QSAR
Report error Found 31 Enz. Inhib. hit(s) with all data for entry = 2339
TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM362182(USRE47267, Compound 137)
Affinity DataIC50: 14nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150812(US8981106, 2 (SX-576) | USRE47267, Compound 2)
Affinity DataIC50: 22nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150824(US8981106, 14 (SX-585) | USRE47267, Compound 14)
Affinity DataIC50: 28nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM362193(USRE47267, Compound 168)
Affinity DataIC50: 32nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150975(US8981106, 165 | USRE47267, Compound 165)
Affinity DataIC50: 37nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150811(US8981106, 1 (SX-517) | USRE47267, Compound 1)
Affinity DataIC50: 38nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150811(US8981106, 1 (SX-517) | USRE47267, Compound 1)
Affinity DataIC50: 38nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150811(US8981106, 1 (SX-517) | USRE47267, Compound 1)
Affinity DataIC50: 38nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150830(US8981106, 19 | USRE47267, Compound 19)
Affinity DataIC50: 72nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150966(US8981106, 155 | USRE47267, Compound 155)
Affinity DataIC50: 78nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM362183(USRE47267, Compound 138)
Affinity DataIC50: 81nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM362192(USRE47267, Compound 167)
Affinity DataIC50: 116nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM362195(USRE47267, Compound 170)
Affinity DataIC50: 166nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150837(US8981106, 26 | USRE47267, Compound 26)
Affinity DataIC50: 173nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150822(US8981106, 13 (SX-578) | USRE47267, Compound 13)
Affinity DataIC50: 277nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150969(US8981106, 159 | USRE47267, Compound 159)
Affinity DataIC50: 278nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150824(US8981106, 14 (SX-585) | USRE47267, Compound 14)
Affinity DataIC50: 1.06E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150915(US8981106, 104 | USRE47267, Compound 104)
Affinity DataIC50: 1.15E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150812(US8981106, 2 (SX-576) | USRE47267, Compound 2)
Affinity DataEC50:  1.25E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150824(US8981106, 14 (SX-585) | USRE47267, Compound 14)
Affinity DataEC50:  1.81E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150968(US8981106, 158 | USRE47267, Compound 158)
Affinity DataIC50: 1.99E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150836(US8981106, 25 | USRE47267, Compound 25)
Affinity DataIC50: 2.12E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150822(US8981106, 13 (SX-578) | USRE47267, Compound 13)
Affinity DataEC50:  2.40E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM362194(USRE47267, Compound 169)
Affinity DataIC50: 3.10E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150860(US8981106, 49 | USRE47267, Compound 49)
Affinity DataIC50: 3.90E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150965(US8981106, 154 | USRE47267, Compound 154)
Affinity DataIC50: 5.00E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150823(US8981106, 13a | USRE47267, Compound 13a)
Affinity DataIC50: 5.00E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150833(US8981106, 22 | USRE47267, Compound 22)
Affinity DataIC50: 5.00E+3nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150971(US8981106, 161 | USRE47267, Compound 161)
Affinity DataIC50: 1.00E+4nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150970(US8981106, 160 | USRE47267, Compound 160)
Affinity DataIC50: 1.00E+4nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

TargetC-X-C chemokine receptor type 2(Human)
Syntrix Biosystems

US Patent
LigandPNGBDBM150976(US8981106, 166 | USRE47267, Compound 166)
Affinity DataIC50: 1.00E+4nMAssay Description:The assay is a Ca2+ mobilization assay that measures changes in intracellular Ca2+ with a FlexStation II scanning fluorometer using a FLIPR-3 Calcium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent